新股孖展统计 | 9月15日

Group 1 - The core viewpoint of the news is that two companies, Jinfang Pharmaceutical-B (02595) and Different Group (06090), are currently in the process of public offering, with significant oversubscription levels reported [1] Group 2 - Jinfang Pharmaceutical-B has received a total of HKD 219.64325 billion in borrowings from various brokers, with an oversubscription rate exceeding 1389 times [1][2] - Different Group has secured HKD 9.3389 billion in borrowings, with an oversubscription rate exceeding 10.9 times [1][2] Group 3 - The total fundraising amount for Jinfang Pharmaceutical-B is HKD 1.58 billion [2] - The total fundraising amount for Different Group is HKD 0.78 billion [2]